{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:05:21Z","timestamp":1777536321676,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1007\/s10495-005-0619-7","type":"journal-article","created":{"date-parts":[[2005,9,8]],"date-time":"2005-09-08T23:47:31Z","timestamp":1126223251000},"page":"1095-1103","source":"Crossref","is-referenced-by-count":31,"title":["Pro-apoptotic effect of a nitric oxide-donating NSAID, NCX 4040, on bladder carcinoma cells"],"prefix":"10.1007","volume":"10","author":[{"given":"F.","family":"Fabbri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Brigliadori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Ulivi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Tesei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Vannini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rosetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Bravaccini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Amadori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bolla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Zoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"619_CR1","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3322\/canjclin.54.3.150","volume":"54","author":"AS Tsao","year":"2004","unstructured":"Tsao AS, Kim ES, Hong WK. Chemoprevention of cancer. CA Cancer J Clin 2004; 54: 150\u2013180.","journal-title":"CA Cancer J Clin"},{"key":"619_CR2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1040-8428(03)00066-0","volume":"46","author":"RJ Cote","year":"2003","unstructured":"Cote RJ, Datar RH. Therapeutic approaches to bladder cancer: Identifying targets and mechanisms. Crit Rev Oncol Hematol 2003; 46: 67\u201383.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"8 Suppl","key":"619_CR3","doi-asserted-by":"crossref","first-page":"S2050","DOI":"10.1002\/cncr.11280","volume":"97","author":"D Raghavan","year":"2003","unstructured":"Raghavan D. Progress in the chemotherapy of metastatic cancer of the urinary tract. Cancer 2003; 97(8 Suppl): S2050\u2013S2055.","journal-title":"Cancer"},{"key":"619_CR4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1040-8428(03)00082-9","volume":"47","author":"J Bellmunt","year":"2003","unstructured":"Bellmunt J, de Wit R, Albiol S, Tabernero J, Albanell J, Baselga J. New drugs and new approaches in metastatic bladder cancer. Crit Rev Oncol Hematol 2003; 47: 195\u2013206.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1 Suppl 3","key":"619_CR5","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1053\/sonc.2002.30750","volume":"29","author":"H Maase von der","year":"2002","unstructured":"von der Maase H. Current and future perspectives in advanced bladder cancer: Is there a new standard? Semin Oncol 2002; 29(1 Suppl 3): S3\u2013S14.","journal-title":"Semin Oncol"},{"issue":"1 Suppl 2","key":"619_CR6","first-page":"S31","volume":"27","author":"CN Sternberg","year":"2000","unstructured":"Sternberg CN. Gemcitabine in bladder cancer. Semin Oncol 2000; 27(1 Suppl 2): S31\u2013S39.","journal-title":"Semin Oncol"},{"issue":"2 Suppl 7","key":"619_CR7","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1053\/j.seminoncol.2004.03.044","volume":"31","author":"AL Sabichi","year":"2004","unstructured":"Sabichi AL, Lippman SM. COX-2 inhibitors and other nonsteroidal anti-inflammatory drugs in genitourinary cancer. Semin Oncol 2004; 31(2 Suppl 7): S36\u2013S44.","journal-title":"Semin Oncol"},{"key":"619_CR8","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1124\/jpet.301.3.1126","volume":"301","author":"SJ Baek","year":"2002","unstructured":"Baek SJ, Wilson LC, Lee CH, Eling TE. Dual function of nonsteroidal anti-inflammatory drugs (NSAIDs): Inhibition of cyclooxygenase and induction of NSAID-activated gene. J Pharmacol Exp Ther 2002; 301: 1126\u20131131.","journal-title":"J Pharmacol Exp Ther"},{"key":"619_CR9","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1172\/JCI118060","volume":"96","author":"SJ Shiff","year":"1995","unstructured":"Shiff SJ, Qiao L, Tsai LL, Rigas B. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J Clin Invest 1995; 96: 491\u2013503.","journal-title":"J Clin Invest"},{"key":"619_CR10","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJM199305063281805","volume":"328","author":"FM Giardiello","year":"1993","unstructured":"Giardiello FM, Hamilton SR, Krush AJ, et al.. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993; 328: 1313\u20131316.","journal-title":"N Engl J Med"},{"key":"619_CR11","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJM200006293422603","volume":"342","author":"G Steinbach","year":"2000","unstructured":"Steinbach G, Lynch PM, Phillips RK, et al.. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000; 342: 1946\u20131952.","journal-title":"N Engl J Med"},{"key":"619_CR12","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1054\/bjoc.1999.1106","volume":"82","author":"JE Castelao","year":"2000","unstructured":"Castelao JE, Yuan JM, Gago-Dominguez M, Yu MC, Ross RK. Non-steroidal anti-inflammatory drugs and bladder cancer prevention. Br J Cancer 2000; 82: 1364\u20131369.","journal-title":"Br J Cancer"},{"issue":"5A","key":"619_CR13","doi-asserted-by":"crossref","first-page":"10S","DOI":"10.1016\/S0002-9343(98)00275-7","volume":"105","author":"A Soll","year":"1998","unstructured":"Soll A. Pathogenesis of nonsteroidal anti-inflammatory drug-related upper gastrointestinal toxicity. Am J Med 1998; 105(5A): 10S\u201316S.","journal-title":"Am J Med"},{"key":"619_CR14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0272-6386(12)80155-7","volume":"24","author":"M Segasothy","year":"1994","unstructured":"Segasothy M, Samad SA, Zulfigar A, Bennett WM. Chronic renal disease and papillary necrosis associated with the long-term use of nonsteroidal anti-inflammatory drugs as the sole or predominant analgesic. Am J Kidney Dis 1994; 24: 17\u201324.","journal-title":"Am J Kidney Dis"},{"key":"619_CR15","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1124\/jpet.102.042754","volume":"303","author":"K Kashfi","year":"2002","unstructured":"Kashfi K, Ryan Y, Qiao LL, et al.. Nitric oxide-donating nonsteroidal anti-inflammatory drugs inhibit the growth of various cultured human cancer cells: Evidence of a tissue type-independent effect. J Pharmacol Exp Ther 2002; 303: 1273\u20131282.","journal-title":"J Pharmacol Exp Ther"},{"key":"619_CR16","first-page":"1297","volume":"22","author":"A Tesei","year":"2003","unstructured":"Tesei A, Ricotti L, Ulivi P, Medri L, Amadori D, Zoli W. NCX 4016, a nitric oxide-releasing aspirin derivative, exhibits a significant antiproliferative effect and alters cell cycle progression in human colon adenocarcinoma cell lines. Int J Oncol 2003; 22: 1297\u20131302.","journal-title":"Int J Oncol"},{"key":"619_CR17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0024-3205(98)00191-X","volume":"62","author":"AW Bak","year":"1998","unstructured":"Bak AW, McKnight W, Li P, et al.. Cyclooxygenase-independent chemoprevention with an aspirin derivative in a rat model of colonic adenocarcinoma. Life Sci 1998; 62: 367\u2013373.","journal-title":"Life Sci"},{"key":"619_CR18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.canlet.2004.06.003","volume":"218","author":"S Huguenin","year":"2005","unstructured":"Huguenin S, Vacherot F, Fleury-Feith J, et al.. Evaluation of the antitumoral potential of different nitric oxide-donating non-steroidal anti-inflammatory drugs (NO-NSAIDs) on human urological tumor cell lines. Cancer Lett 2005; 218: 163\u2013170.","journal-title":"Cancer Lett"},{"key":"619_CR19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1158\/1535-7163.291.3.3","volume":"3","author":"S Huguenin","year":"2004","unstructured":"Huguenin S, Vacherot F, Kheuang L, et al.. Antiproliferative effect of nitrosulindac (NCX 1102), a new nitric oxide-donating non-steroidal anti-inflammatory drug, on human bladder carcinoma cell lines. Mol Cancer Ther 2004; 3: 291\u2013298.","journal-title":"Mol Cancer Ther"},{"key":"619_CR20","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/01.ju.0000132367.02834.41","volume":"172","author":"JS Royle","year":"2004","unstructured":"Royle JS, Ross JA, Ansell I, Bollina P, Tulloch DN, Habib FK. Nitric oxide donating nonsteroidal anti-inflammatory drugs induce apoptosis in human prostate cancer cell systems and human prostatic stroma via caspase-3. J Urol 2004; 172: 338\u2013344.","journal-title":"J Urol"},{"key":"619_CR21","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","volume":"82","author":"P Skehan","year":"1990","unstructured":"Skehan P, Storeng R, Scudiero D, et al.. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990; 82: 1107\u20131112.","journal-title":"J Natl Cancer Inst"},{"key":"619_CR22","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/jnci\/83.11.757","volume":"83","author":"A Monks","year":"1991","unstructured":"Monks A, Scudiero D, Skehan P, et al.. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst 1991; 83: 757\u2013766.","journal-title":"J Natl Cancer Inst"},{"key":"619_CR23","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1158\/1078-0432.CCR-1107-03","volume":"10","author":"W Zoli","year":"2004","unstructured":"Zoli W, Ricotti L, Tesei A, et al.. Schedule-dependent cytotoxic interaction between epidoxorubicin and gemcitabine in human bladder cancer cells in vitro. Clin Cancer Res 2004; 10: 1500\u20131507.","journal-title":"Clin Cancer Res"},{"key":"619_CR24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1479-5876-3-7","volume":"3","author":"A Tesei","year":"2005","unstructured":"Tesei A, Ulivi P, Fabbri F, et al. In vitro and in vivo evaluation of NCX 4040 cytotoxic activity in human colon cancer cell lines. J Transl Med 2005; 3: 7.","journal-title":"J Transl Med"},{"key":"619_CR25","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1096\/fj.02-0297fje","volume":"16","author":"S Fiorucci","year":"2002","unstructured":"Fiorucci S, Mencarelli A, Mannucci R, et al.. NCX-4016, a nitric oxide-releasing aspirin, protects endothelial cells against apoptosis by modulating mitochondrial function. FASEB J 2002; 16: 1645\u20131647.","journal-title":"FASEB J"},{"key":"619_CR26","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1471-4906(01)01904-4","volume":"22","author":"S Fiorucci","year":"2001","unstructured":"Fiorucci S. NO-releasing NSAIDs are caspase inhibitors. Trends Immunol 2001; 22: 232\u2013235.","journal-title":"Trends Immunol"},{"key":"619_CR27","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1158\/0008-5472.CAN-03-3814","volume":"64","author":"F Khwaja","year":"2004","unstructured":"Khwaja F, Allen J, Lynch J, Andrews P, Djakiew D. Ibuprofen inhibits survival of bladder cancer cells by induced expression of the p75NTR tumor suppressor protein. Cancer Res 2004; 64: 6207\u20136213.","journal-title":"Cancer Res"},{"key":"619_CR28","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1097\/01.ju.0000047364.56051.74","volume":"169","author":"RS Pruthi","year":"2003","unstructured":"Pruthi RS, Derksen E, Gaston K. Cyclooxygenase-2 as a potential target in the prevention and treatment of genitourinary tumors: A review. J Urol 2003; 169: 2352\u20132359.","journal-title":"J Urol"},{"key":"619_CR29","first-page":"802","volume":"63","author":"DA Wink","year":"1998","unstructured":"Wink DA, Vodovotz Y, Cook JA, et al.. The role of nitric oxide chemistry in cancer treatment. Biochemistry (Mosc) 1998; 63: 802\u2013809.","journal-title":"Biochemistry (Mosc)"},{"key":"619_CR30","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.molmed.2004.05.004","volume":"10","author":"B Rigas","year":"2004","unstructured":"Rigas B, Kashfi K. Nitric-oxide-donating NSAIDs as agents for cancer prevention. Trends Mol Med 2004; 10: 324\u2013330.","journal-title":"Trends Mol Med"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-005-0619-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10495-005-0619-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-005-0619-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T14:41:38Z","timestamp":1706539298000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10495-005-0619-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["619"],"URL":"https:\/\/doi.org\/10.1007\/s10495-005-0619-7","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}